Skip to search formSkip to main contentSkip to account menu

YM-359445

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperazinesThiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
Purpose: The vascular endothelial growth factor receptor-2 (VEGFR2) tyrosine kinase has been implicated in the pathologic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)